Are you Dr. Rajasingham?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
900 Summit Ave
403
Minneapolis, MN 55403Phone+1 612-701-4564Fax+1 612-676-4009
Summary
- Dr. Radha Rajasingham, MD is an infectious disease specialist in Minneapolis, Minnesota. She is currently licensed to practice medicine in Minnesota and Massachusetts.
Education & Training
University of Minnesota Medical School - DuluthClass of 2008
Certifications & Licensure
MN State Medical License 2014 - 2025
MA State Medical License 2010 - 2015
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With HIV-Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Ant...David B Meya, Elizabeth Nalintya, Caleb P Skipper, Paul Kirumira, Peruth Ayebare
Clinical Infectious Diseases. 2025-02-05 - 1 citationsCauses of HIV-related CNS infection in Cameroon, Malawi, and Tanzania: epidemiological findings from the DREAMM HIV-related CNS implementation study.Cecilia Kanyama, Charles Kouanfack, Saulos Nyirenda, Sayoki Mfinanga, Sokoine Lesikari Kivuyo
The Lancet. Global Health. 2025-02-01 - 2 citationsResolving the CD4-testing crisis to help end AIDS-related deaths.Omar Syarif, Rita Oladele, Tinne Gils, Radha Rajasingham, Jonathan Falconer
The Lancet. Global Health. 2025-01-01
Press Mentions
Africa: Global Strategy to End Cryptococcal Meningitis in People Living with HIVJune 8th, 2021- Can Hydroxychloroquine Prevent COVID-19? We’ll Probably Never KnowAugust 29th, 2020
- In Viral Video, Doctor Falsely Touts Hydroxychloroquine as COVID-19 ‘Cure’July 28th, 2020
- Join now to see all
Grant Support
- Enhanced Antifungal Therapy to Improve Survival in Early Disseminated Cryptococcal InfectionUNIVERSITY OF MINNESOTA2023–2028
- An Enhanced Package of Care to Reduce Mortality in Persons with Advanced HIV DiseaseUNIVERSITY OF MINNESOTA2021–2026
- An Enhanced Package of Care to Reduce Mortality in Persons with Advanced HIV DiseaseUNIVERSITY OF MINNESOTA2021–2026
